Bristol-Myers Squibb Co
XETRA:BRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bristol-Myers Squibb Co
XETRA:BRM
|
US |
|
HKBN Ltd
HKEX:1310
|
HK |
|
G
|
Genting Malaysia Bhd
OTC:GMALY
|
MY |
|
E
|
Erection Electromechanics Testing JSC
VN:LCD
|
VN |
|
C
|
Com2uSCorp
KOSDAQ:078340
|
KR |
|
Z
|
Zions Bancorporation NA
NASDAQ:ZION
|
US |
|
Giyani Metals Corp
XTSX:EMM
|
CA |
Wall Street
Price Targets
BRM Price Targets Summary
Bristol-Myers Squibb Co
According to Wall Street analysts, the average 1-year price target for
BRM
is 53.51 EUR
with a low forecast of 28.44 EUR and a high forecast of 67 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BRM's stock price target?
Price Target
53.51
EUR
According to Wall Street analysts, the average 1-year price target for
BRM
is 53.51 EUR
with a low forecast of 28.44 EUR and a high forecast of 67 EUR.
What is Bristol-Myers Squibb Co's Revenue forecast?
Projected CAGR
-5%
For the last 14 years the
compound annual growth rate for
Bristol-Myers Squibb Co's revenue is
6%.
The projected
CAGR
for the next 3 years is
-5%.
What is Bristol-Myers Squibb Co's Operating Income forecast?
Projected CAGR
-7%
For the last 14 years the
compound annual growth rate for
Bristol-Myers Squibb Co's operating income is
7%.
The projected
CAGR
for the next 3 years is
-7%.
What is Bristol-Myers Squibb Co's Net Income forecast?
Projected CAGR
16%
For the last 14 years the
compound annual growth rate for
Bristol-Myers Squibb Co's net income is
5%.
The projected
CAGR
for the next 3 years is
16%.
